Actionable news
All posts from Actionable news
Actionable news in ABBV: ABBVIE Inc,

Gilead's HCV Prices Are Cheaper In Europe; Will Lawmakers Revolt?

Findings from the Wyden-Grassley report could result in Medicare and Medicaid demanding steeper discounts on Harvoni.

High level data suggests Gilead's HCV regimen is cheaper in Europe than in the U.S. This could cause lawmakers to revolt.

After warring with AIG over executive pay packages, Senator Chuck Grassley is battle-tested.

Cheaper HCV prices in Europe versus the U.S. could get Grassley's dander up again. Avoid GILD.

Anastasia Kelly formerly of AIG. Source:

The recent Wyden-Grassley report on Gilead (NASDAQ:GILD) has caused quite the stir; the 18-month investigation into the pricing and marketing of Gilead's HCV regimen highlighted that [i] Sovaldi's $1,000 per day pill or $84,000 per regimen treatment was designed to maximize revenue, [ii] affordable access was not a key consideration in setting Sovaldi's price and [iii] there was no concrete evidence "that basic financial matters such as R&D costs or the multi-billion dollar acquisition of Pharmasset, the drug's first developer, factored into how Gilead set the price."

I found the allegation that Gilead's HCV pricing was divorced from R&D costs the most troubling. First of all, that was a basic argument by GILD longs to justify the pricing. Secondly, if R&D costs or the cost of acquire Pharmasset were not factors in setting the price, then what separates Gilead from Turing Pharmaceuticals or Valeant (NYSE:VRX)?

GILD Longs Are Apoplectic ...

Longs are apoplectic over the Wyden-Grassley report. Criticisms have ranged from the government singling out Gilead, to socialism, to election year saber rattling. Commenters on my previous article had the following to say:

Commenter 1: This is not about economics or fairness. This is just headline risk in the worst possible environment of an election year.

Commenter 2: Shock Exchange are you a capitalist or socialist? Does public good always translate to socialized medicine with a single (government) payer? So which is for...